Corrigendum to "Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumab" [Int. J. Biol. Macromol. 265(Pt 2) (Apr 2024) 130945]

Int J Biol Macromol. 2024 Sep 19;280(Pt 1):135670. doi: 10.1016/j.ijbiomac.2024.135670. Online ahead of print.
No abstract available

Publication types

  • Published Erratum